Drug intelligence / Profile preview

benzydamine + chlorhexidine (Drogsan Pharmaceuticals)

Development stage
Unknown
Lead developer
Drogsan Pharmaceuticals
Modality
Small Molecules
Administration
Buccal
01

Overview

Siccoral is a fixed-dose combination oropharyngeal spray containing the non-steroidal anti-inflammatory drug (NSAID) benzydamine hydrochloride and the antiseptic chlorhexidine gluconate. Benzydamine provides local analgesic, anesthetic, and anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines (such as TNF-α and IL-1β) and stabilizing cell membranes. Chlorhexidine acts as a broad-spectrum antiseptic by disrupting bacterial cell membranes. Siccoral is primarily used for the symptomatic treatment of inflammatory conditions of the mouth and throat, including pharyngitis, tonsillitis, gingivitis, and stomatitis. In clinical settings, it has been evaluated for its efficacy in preventing and relieving postoperative sore throat (POST) following endotracheal intubation, where it is typically administered as a pre-induction spray.

Brand names
Siccoral
Other names
Siccoral Sprey
02

Targets

Non-specific microbial cell membrane components

Beyond the preview

Go deeper on benzydamine + chlorhexidine (Drogsan Pharmaceuticals).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on benzydamine + chlorhexidine (Drogsan Pharmaceuticals).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call